Ọdịiche dị n’etiti Maninil na Diabeton

Pin
Send
Share
Send

Ojiji nke Maninil na Diabeton kpochapụrụ hyperglycemia, nke na-ebilite n'ihi uto nke ọrịa shuga 2. Abụọ ọgwụ nwere uru na ọghọm. Mgbe ị na-ahọrọ ọgwụ, dọkịta na-eburu n'uche ọtụtụ ihe: ogo nke mmepe nke ọrịa ahụ, ihe kpatara ọdịdị ya, njirimara nke anụ ahụ, mmetụta.

Olee otú Maninil

Maninil bụ onye na-ahụ maka ọgwụ na-egbu egbu nke ihe kachasị arụ ọrụ ya bụ glibenclamide.

Maninil bụ onye na-ahụ maka ọgwụ na-egbu egbu nke ihe kachasị arụ ọrụ ya bụ glibenclamide.

Ọ gụnyekwara:

  • lactose monohydrate;
  • gelatin;
  • talc;
  • steeti magnesium;
  • nduku;
  • nwuo.

Mpempe ntọhapụ ahụ bụ mbadamba mkpụrụ osisi cylindrical dị larịị, nke ọnụọgụ 120 dị na karama iko enweghị agba etinye na ngwungwu kaadiboodu.

Mmetụta ọgwụ ahụ nwere n'ahụ ahụ bụ na mkpụrụ ndụ beta na-eme ka mmepụta insulin. Nke a na - eme na sel nke pancreas mgbe mmadụ riri nri, n'ihi nsonaazụ nke glycemia n'ime ọbara na - ebelata. Mmetụta ọgwụgwọ ahụ na-adịgide otu ụbọchị. A na-etinye ọgwụ ahụ ngwa ngwa na ọ fọrọ obere ka ọ gwụchaa. A na-etinye ntinye uche ya kachasị elu mgbe etinyerechara awa 2.5.

Akụkụ bụ isi dị na ya nwere ike ijikọ protein protein niile. Metabolism nke ihe dị ike na-apụta na sel nke akwara umeji, yana nhazi nke metabolites 2 na-adịghị arụ ọrụ. Mwepu nke otu bu nke mmughari bu nke abuo.

Egosiputara Maninil maka oria abuo. Na mgbakwunye, a ga-eji ọgwụ ahụ mee ihe n'otu oge site na ndị ọzọ na - ahụ maka ọgwụ antidiedi, na mgbakwunye na sulfonylureas na dhoobo.

Egosiputara Maninil maka oria abuo.

Contraindications dị ka ndị a:

  • ụdị shuga 1;
  • mgbochi afọ, paresis nke afọ;
  • nnukwu akwara na oke ịba ọcha n'anya;
  • mgbe a wasịrị ya iji wepụ pancreas;
  • ọrịa mamịrị ketoacidosis;
  • precca mamịrị shuga;
  • leukopenia;
  • enweghi glucose-6-phosphate dehydrogenase;
  • decompensation nke carbohydrate metabolism bụrụ na ọkụ, mmerụ ahụ, ọrịa na-efe efe ma ọ bụ mgbe a wara ya ọgwụ insulin ọgwụ;
  • afọ ruo afọ 18;
  • afọ ime na lactation;
  • mmadụ inabata ya na ọgwụ ndị ahụ.
A na-egbochi Maninil n'ọrịa shuga 1.
Maninil na contraindicated na imeju ọdịda.
A machibidoro Maninil n'afọ ime.
A na-egbochi Maninil na mgbochi afọ.

Ekwesịrị iji nlezianya mee ihe iji mee ka ndị ọrịa nwere oke mmanya na-egbu egbu, ọrịa febrile, ahoụrụma na-adịghị ala ala, ọrịa thyroid na arụ ọrụ, hyperfunction of the face pituitary ma ọ bụ adrenal cortex, ndị ọrịa karịa afọ 70.

Akingụ ọgwụ ahụ nwere ike isonye na mmepe nke nsonaazụ ndị si:

  • digestive: ọgbụgbọ, ọgbụgbọ, oke ibu na afọ, afọ ọsịsa, sọ ọnụ n’onu, mgbu afọ;
  • hematopoietic: thrombocytopenia, leukopenia, erythropenia, agranulocytosis, pancytopenia, hemolytic anemia;
  • ihe mgbochi: urticaria, itching, purpura, petechiae, photoensitivity mụbara, mmeghachi omume nfụkasị ahụ, nke proteinuria, jaundice, fever, skin skin, arthralgia, vasculitis allergies, ụjọ anaphylactic;
  • metabolism: hypoglycemia, nke gosipụtara site na ịma jijiji, agụụ, iro ụra, tachycardia, hyperthermia, isi ọwụwa, nchekasị n'ozuzu oke, mmebi nke mmegharị, iru mmiri nke anụ ahụ, echiche nke ụjọ;
  • imeju na ọnya biliary: ịba ọcha n'anya, chorasis intrahepatic.

Na mgbakwunye, mgbe ị theụsịrị ọgwụ ahụ, ọ nwere ike ịnwe ọhụụ, diuresis nwere ike ịbawanye ụba, proteinuria dị obere, hyponatremia nwere ike ịmalite. N'iji Maninil, ị ga-agbasochi anya ntuziaka nke dọkịta, na-edebe ihe oriri ma na-achịkwa ọkwa nke glucose n'ọbara.

Onye mepụtara ọgwụ ahụ bụ Berlin-Chemie AG, Germany.

Analogs nke Maninil:

  1. Glibenclamide.
  2. Glibamide.
  3. Glidanil.
Inweta Maninil nwere ike ibute nsonaazụ n'ụdị jaundice.
Inweta Maninil nwere ike ibute nsogbu nri.
Inweta Maninil nwere ike ibute nsonaazụ n'ụdị isi ọwụwa.
Inweta Maninil nwere ike ibute nsonaazụ n'ụdị ịma jijiji.

Diabeton Feature

Diabeton bụ ndọtị hypoglycemic gbanwere. Akụkụ bụ isi bụ gliclazide. Ihe mejupụtara ya nwekwara: calcium hydrogen phosphate dihydrate, hypromellose, maltodextrin, magnesium stearate. Odikwa n'ụdị mbadamba biconvex na okpu agha.

Emere ọgwụ a maka ndị ọrịa mamịrị na-arịa ọrịa shuga 2. N'ihi ojiji a na ahụ, ọrụ nke mkpụrụ ndụ beta nke pancreas na-abawanye, nke na-eme ka mmepụta insulin dịkwuo elu.

Ọrịa mamịrị nwere mmetụta bara uru na oke nke mgbidi arịa ọbara, na-eme ka ọnọdụ ha ka mma ma ọ bụ mee ka ọ dị mma.

Ihe mejupụtara ọgwụ ahụ na-ebelata ego cholesterol n'ime ọbara, nke na-ebelata ihe ize ndụ nke ịmalite ọrịa atherosclerosis na microthrombosis. Usoro nke microcirculation ọbara bụ ihe kwesiri ekwesi na ọ bụrụ na ọ na - egbochi mgbochi ọrịa nephropathy. Erere ya na mmamịrị.

Nsonaazụ n'ahụ ahụ ọgwụ dị ka ndị a:

  • normalizes ọkwa shuga;
  • belata ibu;
  • na - egbochi ịmalite ịmịnye ọbara;
  • na-eweghachi mmepụta insulin.

Diabeton bụ ndọtị hypoglycemic gbanwere. Akụkụ bụ isi bụ gliclazide.

Ihe ngosiputa maka iji oria mamiri bu ihe a:

  • ụdị shuga 2;
  • maka nzube prophylactic bụrụ na ọ nwere nsogbu mgbasa ọbara.

A na-eji ọgwụ ahụ ọnụ na ndị ọzọ na - egbochi ọgwụ na - ahụ maka ọgwụgwọ ọrịa shuga dị mgbagwoju anya.

Isi contraindications:

  • ụdị shuga 1;
  • ihe jikọrọ ya na Danazol, Phenylbutazone ma ọ bụ Miconazole;
  • nnukwu akụrụ ma ọ bụ ọrịa ịba ọcha n'anya;
  • precca mamịrị shuga;
  • ọrịa mamịrị ketoacidosis;
  • afọ ime na lactation;
  • afọ ruo afọ 18;
  • ndị mmadụ ịhapụ ịhapụ glucose, galactose, lactose, yana akụkụ nke ọgwụ.

Ibelata contraindications gụnyere:

  • alisụrụma;
  • hypothyroidism;
  • pituitary ma ọ bụ enweghi afọ ojuju;
  • ọrịa obi ike;
  • ịka nká;
  • imeju ma ọ bụ akụrụ afọ;
  • ogologo oge ọgwụgwọ glucocorticosteroids;
  • Enyocha glucose-6-phosphate.
Ọrịa mamịrị na-egbochi egbochi ọbara.
A na-eji onye ọrịa mamịrị dịka ihe mgbochi iji gbochie nsogbu mgbasa ọbara.
Ọrịa mamịrị na-ebelata ibu.
Ọrịa mamịrị na-eme ka ogo shuga dị.
Ọrịa mamịrị weghachitere insulin.
A na-eji ndị ọrịa mamịrị maka ụdị shuga 2.

Ihe mgbagwoju anya gunyere mmepe nke hypoglycemia. Mgbaàmà ya gụnyere isi ọwụwa, ọgbụgbọ, mgbakasị uche, belata itinye uche, ike ọgwụgwụ, ọgbụgbọ, iku ume, ọgba aghara, njide onwe onye, ​​nkụda mmụọ, mmeghachi nwayọ.

Na mgbakwunye, mmadụ nwere ike ịchọpụta iwe, obi nkoropụ, mmetụta nke enweghị enyemaka, aphasia, ọhụhụ anya na okwu, bradycardia, cramps, adịghị ike, mwepu nke mmụọ, nke nwere ike isonyere mmepe nke coma.

Mmetụta dị n'akụkụ ya gụnyere mmeghachi omume adrenergic: arrhythmia, angina pectoris, ọbara mgbali elu, nchekasị, tachycardia, ịsụsọ nke ukwuu.

Usoro nri nwere ike ọghọm ya na ọgbụgbọ, ọgbụgbọ, mgbu afọ, afọ ọsịsa, na afọ ntachi nwere ike ibilite. A na-ahụta nsogbu ọbara ọgbụgba site na akwara hemopoietic na sistem lymphatic: anaemia, granulocytopenia, thrombocytopenia, leukopenia. Itching, hives, ihe ọghọm, mmeghachi omume jọgburu onwe ya, iro nke maculopapular, edeme Quincke, erythema ga-ekwe omume. Ahụhụ a na-ahụ anya nwere ike ị nweta nsogbu na-apụtaghị ìhè nwa oge.

Ndị na-emepụta Diabeton bụ ụlọ ọrụ "Servier", France. Ihe analogues ya gụnyere: Glimepiride, Glibiab, Gliklazid-Akos, Glibenclamide, Glycvidon, Maninil.

Ọrịa shuga na-ebelata shuga

Tụnyere Maninil na Diabeton

Ọgwụ abụọ ahụ nwere ọtụtụ ihe jikọrọ ha, mana enwere ọdịiche n'etiti ha.

Mmekorita

Maninil na Diabeton na-etinye obi gị dum ma na-ebelata shuga dị n'ọbara. Edere ha maka ọrịa shuga 2, ha abụọ bụ ụdị nke mbu. Ha nwere ọtụtụ nsonaazụ na contraindications. Edepụtara ha na-enweghị ọgwụ dọkịta.

Kedu ihe dị iche

Maninil na contraindicated na oke ndị mmadụ, dị ka na - eduga n'ịba ụba nke oke. Ọgwụ ndị ahụ nwere ndị nrụpụta na ihe mejupụtara.

Kedu nke dị ọnụ ala

Ọnụ ego nke Maninil bụ 131 rubles, na Diabeton bụ 281 rubles.

Kedu nke ka mma - Maninil ma ọ bụ Ọrịa mamịrị

Whichhọrọ nke ka mma - Maninil ma ọ bụ Ọrịa mamịrị, dọkịta ahụ na-atụle njirimara nke ahụ onye ọrịa mgbe nyocha na mkpebi nke ọ̀tụ̀tụ̀ glucose ọbara. Ọ aghaghi ichebara nsonaazụ ule, ọrịa dị na contraindications.

Na-arịa ọrịa shuga

Site n'ọrịa dị otú ahụ, ndị dọkịta na-ekwukarị ndị ọrịa shuga ugboro ugboro, nke ọ na-ebelata ihe ize ndụ nke ịmalite ọrịa microro na nnukwu nsogbu nke ọrịa shuga n'ihi mmetụta haemovascular. Nke a ga - enyere gị aka ịgbatị ndụ onye ọrịa ma melite ogo ya.

Maninil na contraindicated na oke ndị mmadụ, dị ka na - eduga n'ịba ụba nke oke.

Nyocha nyocha Ndidi

Dmitry, dị afọ 59, Volgograd: “Anọwo m na-arịa ọrịa shuga ogologo oge. Enwere m ike belata ọkwa shuga dị m n'ọbara, ọbụlagodi na nri siri ike .. Dọkịta na-aga ya debara aha Maninil, ekele nke shuga belatara site na nkeji 17 ruo 7 n'ime ọnwa 2. Echere m. nke ahụ bụ ezigbo nsonaazụ. "

Irina, onye dị afọ 65, Moscow: “Anọwo m arịa ọrịa shuga ruo ọtụtụ afọ, ọtụtụ ọgwụ enyereghị m aka. Na nso nso a, dọkịta depụtara Maninil. Na mbụ, m were mbadamba mbido 1, ma mesịa gbanye abụọ, n'ihi na m na-agagharị ntakịrị na otu ọgwụ anaghị enwe shuga. ọ nweghị mmetụta ọ bụla, ọ bụ ezie na m na-atụ ha egwu. "

Igor, onye gbara afọ 49, Ryazan: “Aria m ọrịa shuga afọ atọ gara aga. Amalitere m iso nri siri ike, were Metformin na Galvus. Ma ọkwa glucose m belatara. Dọkịta tụrụ aro ka ọrịa mamịrị. Elere m ya n'anyasị, mgbe ọ gbasịrị atọ, shuga m gbadara ruo 4 , Nkeji atọ. ”

Nyocha ndị dọkịta banyere Maninil na Diabeton

Olga, ọkà mmụta ọgwụ endocrinologist, Moscow: “Ana m agwa ndị ọrịa maka ọrịa shuga yana nri shuga. M na-ahọrọ otu ọgwụ nke ọgwụ iji gbochie mmepe nke mmetụta.”

Maria, endocrinologist, Kemerovo: "Ọtụtụ mgbe, m na-edenye ndị ọrịa mamịrị ọgwụ Ọrịa shuga. Ọ na-ebelata shuga ọbara. Ọ fọrọ nke nta ka ọ ghara ịnwe ọrịa hypoglycemia, yabụ enwere ike iji ndị ọrịa nwere ọrịa obi.

Pin
Send
Share
Send